Comparison Overview

Eastern Biotech & Life Sciences

VS

bioMérieux

Eastern Biotech & Life Sciences

Elite Business Center, Dubai, 0000, AE
Last Update:
View Profile
Between 700 and 749
http://www.easternbiotech.com/

Eastern Biotech & Life Sciences based at DuBiotech, Dubai, is the first company in the Middle East to offer comprehensive genetic testing services. We have carefully examined the biotechnological horizon to identify the genetic tests most relevant to this region and offer them directly to the people of the Middle East. www.easternbiotech.com www.easternbiotech.ae www.foodintolerancetest.ae www.dnaancestry.ae www.geneticcounseling.ae www.telomeretest.ae

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 13
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

bioMérieux

100, Allée Louis Pasteur, Marcy-l'Étoile, 69280, FR
Last Update: 2026-04-01
Between 750 and 799
https://www.biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 12,827
Subsidiaries: 6
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/eastern-biotech-&-life-sciences.jpeg
Eastern Biotech & Life Sciences
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/biomerieux.jpeg
bioMérieux
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Eastern Biotech & Life Sciences
100%
Compliance Rate
0/4 Standards Verified
bioMérieux
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Eastern Biotech & Life Sciences in 2026.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for bioMérieux in 2026.

Incident History — Eastern Biotech & Life Sciences (X = Date, Y = Severity)

Eastern Biotech & Life Sciences cyber incidents detection timeline including parent company and subsidiaries

Incident History — bioMérieux (X = Date, Y = Severity)

bioMérieux cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/eastern-biotech-&-life-sciences.jpeg
Eastern Biotech & Life Sciences
Incidents

No Incident

https://images.rankiteo.com/companyimages/biomerieux.jpeg
bioMérieux
Incidents

Date Detected: 6/2023
Type:Vulnerability
Attack Vector: Unauthorized Access
Blog: Blog

FAQ

bioMérieux company demonstrates a stronger AI Cybersecurity Score compared to Eastern Biotech & Life Sciences company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

bioMérieux company has historically faced a number of disclosed cyber incidents, whereas Eastern Biotech & Life Sciences company has not reported any.

In the current year, bioMérieux company and Eastern Biotech & Life Sciences company have not reported any cyber incidents.

Neither bioMérieux company nor Eastern Biotech & Life Sciences company has reported experiencing a ransomware attack publicly.

Neither bioMérieux company nor Eastern Biotech & Life Sciences company has reported experiencing a data breach publicly.

Neither bioMérieux company nor Eastern Biotech & Life Sciences company has reported experiencing targeted cyberattacks publicly.

bioMérieux company has disclosed at least one vulnerability, while Eastern Biotech & Life Sciences company has not reported such incidents publicly.

Neither Eastern Biotech & Life Sciences nor bioMérieux holds any compliance certifications.

Neither company holds any compliance certifications.

bioMérieux company has more subsidiaries worldwide compared to Eastern Biotech & Life Sciences company.

bioMérieux company employs more people globally than Eastern Biotech & Life Sciences company, reflecting its scale as a Biotechnology Research.

Neither Eastern Biotech & Life Sciences nor bioMérieux holds SOC 2 Type 1 certification.

Neither Eastern Biotech & Life Sciences nor bioMérieux holds SOC 2 Type 2 certification.

Neither Eastern Biotech & Life Sciences nor bioMérieux holds ISO 27001 certification.

Neither Eastern Biotech & Life Sciences nor bioMérieux holds PCI DSS certification.

Neither Eastern Biotech & Life Sciences nor bioMérieux holds HIPAA certification.

Neither Eastern Biotech & Life Sciences nor bioMérieux holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Published
Date
2026-04-02
Updated
Date
2026-04-02
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References